Chronisch Lymphatische Leukämie Guidline and Quality indicator
0.2.0 - ci-build
Chronisch Lymphatische Leukämie Guidline and Quality indicator - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Active as of 2023-05 |
{
"resourceType" : "PlanDefinition",
"id" : "CLLTherapieindikationBinetAB",
"meta" : {
"profile" : [
🔗 "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: PlanDefinition CLLTherapieindikationBinetAB</b></p><a name=\"CLLTherapieindikationBinetAB\"> </a><a name=\"hcCLLTherapieindikationBinetAB\"> </a><a name=\"CLLTherapieindikationBinetAB-en-US\"> </a><p><b>partOf</b>: <a href=\"PlanDefinition-RecCollectionTherapieplanungBinetCLL.html\">Recommendation Collection CLL: Therapieindikation nach Binet Stadium (4.1)</a></p><blockquote><p><b>Action Combination Method</b></p><ul><li>method: <span title=\"Codes:{https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method all}\">All</span></li></ul></blockquote><p><b>knowledgeCapability</b>: computable</p><p><b>knowledgeRepresentationLevel</b>: structured</p><p><b>url</b>: <a href=\"PlanDefinition-CLLTherapieindikationBinetAB.html\">PlanDefinition CLL Therapieindikation Binet A B</a></p><p><b>version</b>: Langversion 2.01</p><p><b>name</b>: CLLTherapieindikationBinetAB</p><p><b>title</b>: CLL Therapieindikation Binet A B</p><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type eca-rule}\">ECA Rule</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: false</p><p><b>subject</b>: <a href=\"EvidenceVariable-PopulationCLLBinetAB.html\">Population: CLL und Binet Stadium AB </a></p><p><b>date</b>: 2023-05</p><p><b>publisher</b>: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll</p><p><b>description</b>: </p><div><p>Die Indikation zur Therapie in Abhängigkeit der Symptomatik wenn Binet A oder B vorliegt</p>\n</div><h3>Actions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Definition[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 74964007}\">Other (qualifier value)</span></td><td><a href=\"ActivityDefinition-TherapieIndikationCLL.html\">TherapieIndikationCLL</a></td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-partOf",
"valueCanonical" : "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/therapeutic-anticoagulation"
},
{
"extension" : [
{
"url" : "method",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method",
"code" : "all"
}
]
}
}
],
"url" : "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method"
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
"valueCode" : "computable"
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
"valueCode" : "structured"
}
],
"url" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/PlanDefinition/CLLTherapieindikationBinetAB",
"version" : "Langversion 2.01",
"name" : "CLLTherapieindikationBinetAB",
"title" : "CLL Therapieindikation Binet A B",
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
"code" : "eca-rule"
}
]
},
"status" : "active",
"experimental" : false,
"subjectCanonical" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/EvidenceVariable/PopulationCLLBinetAB",
"date" : "2023-05",
"publisher" : "https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll",
"description" : "Die Indikation zur Therapie in Abhängigkeit der Symptomatik wenn Binet A oder B vorliegt",
"action" : [
{
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "74964007",
"display" : "Other (qualifier value)"
}
]
},
"definitionCanonical" : "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/TherapieIndikationCLL"
}
]
}